1. Home
  2. RDY vs GL Comparison

RDY vs GL Comparison

Compare RDY & GL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • GL
  • Stock Information
  • Founded
  • RDY 1984
  • GL 1900
  • Country
  • RDY India
  • GL United States
  • Employees
  • RDY N/A
  • GL N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • GL Life Insurance
  • Sector
  • RDY Health Care
  • GL Finance
  • Exchange
  • RDY Nasdaq
  • GL Nasdaq
  • Market Cap
  • RDY 11.9B
  • GL 9.7B
  • IPO Year
  • RDY N/A
  • GL N/A
  • Fundamental
  • Price
  • RDY $15.38
  • GL $109.44
  • Analyst Decision
  • RDY Buy
  • GL Buy
  • Analyst Count
  • RDY 1
  • GL 10
  • Target Price
  • RDY $17.00
  • GL $127.10
  • AVG Volume (30 Days)
  • RDY 1.6M
  • GL 879.3K
  • Earning Date
  • RDY 01-28-2025
  • GL 02-05-2025
  • Dividend Yield
  • RDY 3.74%
  • GL 0.88%
  • EPS Growth
  • RDY 4.63
  • GL 22.14
  • EPS
  • RDY 0.76
  • GL 11.80
  • Revenue
  • RDY $3,579,112,656.00
  • GL $5,727,483,000.00
  • Revenue This Year
  • RDY $13.39
  • GL N/A
  • Revenue Next Year
  • RDY $8.35
  • GL $5.58
  • P/E Ratio
  • RDY $20.68
  • GL $9.27
  • Revenue Growth
  • RDY 12.37
  • GL 6.72
  • 52 Week Low
  • RDY $13.41
  • GL $38.95
  • 52 Week High
  • RDY $16.89
  • GL $132.00
  • Technical
  • Relative Strength Index (RSI)
  • RDY 66.14
  • GL 57.19
  • Support Level
  • RDY $14.45
  • GL $103.88
  • Resistance Level
  • RDY $14.85
  • GL $107.57
  • Average True Range (ATR)
  • RDY 0.19
  • GL 3.44
  • MACD
  • RDY 0.13
  • GL 0.13
  • Stochastic Oscillator
  • RDY 88.17
  • GL 87.67

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into four reportable segments: life insurance, supplemental health insurance, annuities, and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

Share on Social Networks: